Food effect substudy of a phase 3 randomized double-blind trial of maintenance with niraparib (MK4827), a poly(ADP)ribose polymerase (PARP) inhibitor versus placebo in patients with platinum-sensitive ovarian cancer.
Kathleen N. Moore
No relevant relationships to disclose
Zhi-Yi Zhang
Employment or Leadership Position - Tesaro
Stock Ownership - Tesaro
Shefali Agarwal
Employment or Leadership Position - Tesaro
Stock Ownership - Tesaro
Manish R. Patel
No relevant relationships to disclose
Howard A. Burris
No relevant relationships to disclose
Robert E. Martell
Employment or Leadership Position - Tesaro
Stock Ownership - Tesaro
Vikram Kansra
Employment or Leadership Position - Tesaro
Stock Ownership - Tesaro